Literature DB >> 5009023

Leukapheresis therapy of chronic lymphocytic leukemia.

J E Curtis, E M Hersh, E J Freireich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5009023

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

Review 1.  Clinical applications of the continuous flow blood separator machine.

Authors:  C J Oon; J R Hobbs
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

2.  A case of the Sezary syndrome.

Authors:  J G McCormack; P D Holland; D Pounder
Journal:  Ir J Med Sci       Date:  1978-07       Impact factor: 1.568

3.  Chronic lymphocytic leukemia.

Authors:  D W Martin; R C Siegel; L H Smith
Journal:  West J Med       Date:  1977-09

4.  Leucapheresis in severe rheumatoid arthritis.

Authors:  J Tenenbaum; M B Urowitz; E C Keystone; I L Dwosh; J E Curtis
Journal:  Ann Rheum Dis       Date:  1979-02       Impact factor: 19.103

5.  [Therapeutic, functional and kinetic aspects of leukopheresis therapy in chronic lymphatic leukemia].

Authors:  P Höcker; E Pittermann; M Gobets; B Haist; M Gazda; A Stacher
Journal:  Blut       Date:  1974-06

6.  Induced resistance to ofatumumab-mediated cell clearance mechanisms, including complement-dependent cytotoxicity, in chronic lymphocytic leukemia.

Authors:  Nisar A Baig; Ronald P Taylor; Margaret A Lindorfer; Amy K Church; Betsy R LaPlant; Adam M Pettinger; Tait D Shanafelt; Grzegorz S Nowakowski; Clive S Zent
Journal:  J Immunol       Date:  2014-01-15       Impact factor: 5.422

7.  [Successful treatment of thyroid storm by continuous plasmapheresis with a blood-cell separator (author's transl)].

Authors:  K Horn; G Brehm; J Habermann; C R Pickardt; P C Scriba
Journal:  Klin Wochenschr       Date:  1976-10-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.